<table id="t14" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 14. Mean<footnote>The majority of parameter means determined in each study had coefficients of variation between 20% and 40% for half-life and Cl/F and between 30% and 70% for T<sub>max.</sub> The overall mean values were calculated from individual study means that were weighted based on the number of volunteers/patients in each study. The numbers in parentheses below each parameter mean represent the range of individual volunteer/patient values across studies.</footnote> Pharmacokinetic Parameters in Healthy Volunteers and Adult Patients With Epilepsy</caption>
<col align="left" valign="bottom" width="20%"></col>
<col align="center" valign="bottom" width="20%"></col>
<col align="center" valign="bottom" width="20%"></col>
<col align="center" valign="bottom" width="20%"></col>
<col align="center" valign="bottom" width="20%"></col>
<thead>
<tr>
<th stylecode="Lrule" valign="middle">Adult Study Population</th>
<th>Number of Subjects</th>
<th>T<sub>max</sub>: Time of Maximum Plasma Concentration<br/>(hr)</th>
<th>t<sub>½</sub>: Elimination Half-life<br/>(hr)</th>
<th stylecode="Rrule">Cl/F: Apparent Plasma Clearance<br/>(mL/min/kg)</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule">
<content stylecode="bold">Healthy volunteers taking no other medications:</content>
</td>
<td></td>
<td></td>
<td></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule">  Single-dose Lamotrigine</td>
<td>179</td>
<td>2.2</td>
<td>32.8</td>
<td stylecode="Rrule">0.44</td>
</tr>
<tr>
<td stylecode="Lrule"></td>
<td></td>
<td>(0.25-12.0) </td>
<td>(14.0-103.0)</td>
<td stylecode="Rrule">(0.12-1.10)</td>
</tr>
<tr>
<td stylecode="Lrule">  Multiple-dose Lamotrigine</td>
<td>36</td>
<td>1.7</td>
<td>25.4</td>
<td stylecode="Rrule">0.58</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule"></td>
<td></td>
<td>(0.5-4.0)</td>
<td>(11.6-61.6)</td>
<td stylecode="Rrule">(0.24-1.15)</td>
</tr>
<tr>
<td stylecode="Lrule">
<content stylecode="bold">Healthy volunteers taking valproate:</content>
</td>
<td></td>
<td></td>
<td></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule">  Single-dose Lamotrigine   </td>
<td>6</td>
<td>1.8</td>
<td>48.3</td>
<td stylecode="Rrule">0.30</td>
</tr>
<tr>
<td stylecode="Lrule"></td>
<td></td>
<td>(1.0-4.0)  </td>
<td>(31.5-88.6)</td>
<td stylecode="Rrule">(0.14-0.42)</td>
</tr>
<tr>
<td stylecode="Lrule">  Multiple-dose Lamotrigine</td>
<td>18</td>
<td>1.9</td>
<td>70.3</td>
<td stylecode="Rrule">0.18</td>
</tr>
<tr>
<td stylecode="Lrule"></td>
<td></td>
<td>(0.5-3.5)  </td>
<td>(41.9-113.5)</td>
<td stylecode="Rrule">(0.12-0.33)</td>
</tr>
<tr>
<td stylecode="Lrule">
<content stylecode="bold">Patients with epilepsy taking valproate only:</content>
</td>
<td></td>
<td></td>
<td></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule">  Single-dose Lamotrigine    </td>
<td>4</td>
<td>4.8</td>
<td>58.8</td>
<td stylecode="Rrule">0.28</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule"></td>
<td></td>
<td>(1.8-8.4)</td>
<td>(30.5-88.8)</td>
<td stylecode="Rrule">(0.16-0.40)</td>
</tr>
<tr>
<td stylecode="Lrule">
<content stylecode="bold">Patients with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="ft14.1">Carbamazepine, phenobarbital, phenytoin, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and other drugs such as rifampin that induce lamotrigine glucuronidation have also been shown to increase the apparent clearance of lamotrigine <content stylecode="italics">[see <linkhtml href="#S7">Drug Interactions (7)</linkhtml>].</content>
</footnote> plus valproate:</content>
</td>
<td></td>
<td></td>
<td></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule" valign="top">
<td stylecode="Lrule">  Single-dose Lamotrigine</td>
<td>25</td>
<td>3.8<br/>(1.0-10.0)</td>
<td>27.2<br/>(11.2-51.6)</td>
<td stylecode="Rrule">0.53<br/>(0.27-1.04)</td>
</tr>
<tr>
<td stylecode="Lrule">
<content stylecode="bold">Patients with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="ft14.1"></footnoteref>:</content>
</td>
<td></td>
<td></td>
<td></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule">  Single-dose Lamotrigine   </td>
<td>24</td>
<td>2.3</td>
<td>14.4</td>
<td stylecode="Rrule">1.10</td>
</tr>
<tr>
<td stylecode="Lrule"></td>
<td></td>
<td>(0.5-5.0)  </td>
<td>(6.4-30.4)</td>
<td stylecode="Rrule">(0.51-2.22)</td>
</tr>
<tr>
<td stylecode="Lrule">  Multiple-dose Lamotrigine    </td>
<td>17</td>
<td>2.0</td>
<td>12.6</td>
<td stylecode="Rrule">1.21</td>
</tr>
<tr>
<td stylecode="Lrule"></td>
<td></td>
<td>(0.75-5.93) </td>
<td>(7.5-23.1) </td>
<td stylecode="Rrule">(0.66-1.82)</td>
</tr>
</tbody>
</table>